Understanding hospital-acquired respiratory virus infections
Official title: Hospital-acquired Respiratory Viral Infection: A Prospective Multicenter Study in France
Run by Hospices Civils de Lyon · NCT06643039 · Data updated 2026-11-12
This study is trying to learn more about respiratory virus infections that people catch in hospitals and see how vaccines might help prevent them.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 6 sites (Bordeaux and 5 other locations) |
| Status | Recruiting |
| Started | December 5, 2024 |
| Main results expected | July 5, 2027 |
| Study ends | July 5, 2027 |
| Registry record updated | October 1, 2026 |
| Trial ID | NCT06643039 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 years old who are hospitalized or healthcare professionals presenting with influenza-like symptoms.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or under legal protection measures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to investigate hospital-acquired viral respiratory infections (HAVRI) in France, focusing on their epidemiology and the impact of vaccination on prevention. It will involve a multicenter approach across four hospitals, collecting data from hospitalized patients and healthcare professionals presenting with influenza-like illness. Participants will undergo nasopharyngeal swabs and complete questionnaires to gather clinical characteristics and potential sources of transmission. The goal is to enhance understanding of HAVRI and improve infection control measures.
Why it matters
Potential benefit: If successful, this study could lead to improved prevention strategies and reduced incidence of hospital-acquired respiratory infections.
How similar studies have gone: Other studies have shown success in understanding and controlling nosocomial infections, making this approach promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults\> 18 years old * Hospitalized patient or health care professionals presenting an ILI on admission or during the stay, meeting the following definition: fever greater than 37.8° C in the absence of taking antipyretics and/or cough or pharyngeal pain. * Signed consent form Exclusion Criteria: * Pregnant, parturient or breastfeeding women * individuals deprived of their liberty by a judicial or administrative decision * Individuals subject to psychiatric care * Individuals admitted to a health or social establishment for purposes other than research * Individuals under a legal protection measure (guardianship, curatorship) * Individuals not affiliated to a social security insurance
Where it's running
-
Edouard Herriot Hospital
Lyon, France Recruiting -
Pellegrin Hospital
Bordeaux, France Not yet recruiting -
CHU Dijon
Dijon, France Not yet recruiting -
Saint Louis Hospital
Paris, France Not yet recruiting -
Bichat Hospital
Paris, France Not yet recruiting -
Saint Louis Hospital
Paris, France Not yet recruiting
Study contacts
- Study coordinator: Philippe VANHEMS, MD, PhD
- Email: Philippe.vanhems@chu-lyon.fr
- Phone: +33 4 72 11 07 20
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rapid test for Candida auris detection in hospital patients
This study tests a quick rapid diagnostic test to see if it can correctly identify Candida auris in patient samples compared with the standard lab method.
-
Blood viscosity in ARDS: a look at how thick the blood is
This study tests whether blood viscosity is higher in adults with ARDS and whether viscosity relates to their breathing and blood flow issues.
-
Virus interactions in hospitalized patients during winter seasons in Lyon
This study tests all virological results from hospitalized patients in Lyon during winter to see how different respiratory viruses may co-occur or exclude each other.
-
Surgical Use of Efanoctocog alfa in Hemophilia A Patients
This observational study looks at how efanesoctocog alfa (Altuvoct) is used around surgery in people with hemophilia A to see if it helps control bleeding.
-
Sleep quality and its determinants during the liver transplant pathway
This study tests how sleep quality changes from before liver transplantation to six months after, in adults on the transplant waitlist at a single hospital.
-
Compare Trans-Stomal Bladder Lithotripsy Methods in Continent Catheterizable Urinary Reservoirs
This study looks at different ways to break up bladder stones in people with continent catheterizable urinary diversions to see which method works best when the normal route isn’t available.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.